Stifel Reiterates Buy Rating on Rapport Therapeutics (RAPP)
Go back to Stifel Reiterates Buy Rating on Rapport Therapeutics (RAPP)| R & A Productions, Inc. Common (NASDAQ: RAPP) | Delayed: 40.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.79 | 52 Week High | $3.75 | |||
| Open | $40.78 | 52 Week Low | $0.25 | |||
| Day High | $42.10 | P/E | 4,079.00 | |||
| Day Low | $39.75 | EPS | $0.01 | |||
| Volume | 121 | |||||
